Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 8:18 pm Purchase | 2021-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Avidity Partners Management LP | 2,205,687 7.300% | 735,297 (+50.01%) | Filing History |
| 2022-02-11 8:10 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Avidity Partners Management LP | 1,278,261 5.900% | 1,278,261 (New Position) | Filing History |
| 2022-02-11 7:52 pm Purchase | 2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Avidity Partners Management LP | 4,405,000 9.200% | 120,000 (+2.80%) | Filing History |
| 2022-02-11 7:43 pm Sale | 2021-12-31 | 13G | IVERIC bio, Inc. ISEE | Avidity Partners Management LP | 6,955,000 6.100% | -270,000 (-3.74%) | Filing History |
| 2022-02-11 7:18 pm Purchase | 2021-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Avidity Partners Management LP | 6,990,194 9.900% | 2,443,380 (+53.74%) | Filing History |
| 2022-02-11 7:12 pm Sale | 2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF | Avidity Partners Management LP | 0 0.000% | -2,153,600 (Position Closed) | Filing History |
| 2022-02-11 6:54 pm Sale | 2021-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Avidity Partners Management LP | 0 0.000% | -731,000 (Position Closed) | Filing History |
| 2022-02-11 6:31 pm Purchase | 2021-12-31 | 13G | Adicet Bio, Inc. ACET | Avidity Partners Management LP | 3,034,004 7.900% | 1,174,004 (+63.12%) | Filing History |
| 2022-02-11 6:24 pm Purchase | 2021-12-31 | 13G | SeaSpine Holdings Corporation SPNE | Avidity Partners Management LP | 2,010,000 5.500% | 2,010,000 (New Position) | Filing History |
| 2022-02-11 6:16 pm Purchase | 2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Avidity Partners Management LP | 1,896,000 6.000% | 1,896,000 (New Position) | Filing History |
| 2022-02-11 6:07 pm Purchase | 2021-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | Avidity Partners Management LP | 1,849,538 5.200% | 1,849,538 (New Position) | Filing History |
| 2022-02-01 3:33 pm Purchase | 2022-01-25 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Avidity Partners Management LP | 3,022,790 6.700% | 3,022,790 (New Position) | Filing History |
| 2022-01-03 12:09 pm Purchase | 2021-12-30 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 322,820 6.600% | 322,820 (New Position) | Filing History |
| 2022-01-03 12:07 pm Purchase | 2021-12-30 | 13G | Altimmune, Inc. ALT | Avidity Partners Management LP | 2,765,000 7.000% | 2,765,000 (New Position) | Filing History |
| 2021-12-01 11:04 am Purchase | 2021-11-30 | 13G | IDEAYA Biosciences, Inc. IDYA | Avidity Partners Management LP | 2,470,179 6.400% | 2,470,179 (New Position) | Filing History |
| 2021-10-27 6:12 pm Purchase | 2021-10-21 | 13G | Viridian Therapeutics, Inc. VRDN | Avidity Partners Management LP | 1,120,925 6.600% | 1,120,925 (New Position) | Filing History |
| 2021-10-25 10:36 am Purchase | 2021-10-22 | 13G | IVERIC bio, Inc. ISEE | Avidity Partners Management LP | 7,225,000 7.000% | 7,225,000 (New Position) | Filing History |
| 2021-04-20 4:34 pm Purchase | 2021-04-20 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Avidity Partners Management LP | 4,750,000 9.900% | 1,442,000 (+43.59%) | Filing History |
| 2021-03-22 4:05 pm Purchase | 2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Avidity Partners Management LP | 4,285,000 9.400% | 4,285,000 (New Position) | Filing History |
| 2021-02-16 4:46 pm Purchase | 2020-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | Avidity Partners Management LP | 1,470,390 6.200% | 132,977 (+9.94%) | Filing History |